Mirzaee Sam, Isa Mourushi, Thakur Udit, Cameron James D, Nicholls Stephen J, Dundon Benjamin K
Monash Cardiovascular Research Centre, MonashHeart, Monash Health, Melbourne, Australia, Monash University - 246 Clayton Road, Clayton, VIC 3168 Australia.
J Invasive Cardiol. 2020 Feb;32(2):42-48. doi: 10.25270/jic/19.00235. Epub 2020 Jan 20.
Despite the high prevalence of coronary bifurcation lesions in routine interventional cardiology practice, the best strategy for managing this challenging lesion subset remains debatable. Due to potential for complications, the routine practice of side-branch (SB) predilation is controversial.
An electronic search was performed of online databases up until April 2018 for studies reporting periprocedural angiographic outcomes comparing provisional main-branch stenting with and without SB predilation. Random-effects model odds ratios (ORs) were calculated.
Eight studies were selected for a qualitative review, with 47.3% (1367/2890) of included subjects having angiographic outcomes following SB predilation reported. Of these, four studies included details of periangiographic outcomes comparing two groups. Bifurcation lesions stented without SB predilation demonstrated lower odds of requiring further SB intervention compared with lesions receiving upfront SB predilation (OR, 2.44; 95% confidence interval [CI], 1.71-3.47; I²=21%; P<.001). No difference was demonstrated regarding final SB TIMI flow <3, SB dissection, or intraprocedural SB occlusion. Although the odds of performing final kissing-balloon inflation were in favor of the group without SB predilation (OR, 1.62; 95% CI, 1.11-2.37; I²=61%; P=.01), there was no statistical difference in long-term major cardiovascular outcome (MACE) between the two groups (risk ratio, 1.29; 95% CI, 0.94-1.75; I²=11%; P=.33).
SB predilation during coronary bifurcation percutaneous coronary intervention did not alter overall procedural angiographic outcomes. However, SB predilation is associated with increased SB intervention, including increased requirement for SB stenting, without demonstrable long-term MACE benefit, compared with a standard strategy without SB predilation.
尽管在常规介入心脏病学实践中冠状动脉分叉病变的患病率很高,但处理这一具有挑战性的病变亚组的最佳策略仍存在争议。由于存在并发症的可能性,边支(SB)预扩张的常规做法存在争议。
截至2018年4月,对在线数据库进行电子检索,以查找报告比较有和没有SB预扩张的临时主支支架置入术围手术期血管造影结果的研究。计算随机效应模型优势比(OR)。
八项研究被选作定性综述,其中47.3%(1367/2890)的纳入受试者报告了SB预扩张后的血管造影结果。其中,四项研究包括比较两组血管造影结果的详细信息。与接受预先SB预扩张的病变相比,未进行SB预扩张而置入支架的分叉病变需要进一步SB干预的几率更低(OR,2.44;95%置信区间[CI],1.71 - 3.47;I² = 21%;P <.001)。在最终SB TIMI血流<3、SB夹层或术中SB闭塞方面未显示出差异。尽管进行最终球囊对吻扩张的几率有利于未进行SB预扩张的组(OR,1.62;95% CI,1.11 - 2.37;I² = 61%;P =.01),但两组之间的长期主要心血管结局(MACE)无统计学差异(风险比,1.29;95% CI,0.94 - 1.75;I² = 11%;P =.33)。
冠状动脉分叉经皮冠状动脉介入治疗期间的SB预扩张并未改变总体手术血管造影结果。然而,与不进行SB预扩张的标准策略相比,SB预扩张与SB干预增加相关,包括对SB支架置入需求的增加,且未显示出长期MACE获益。